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Abstract: This article examines the legal and ethical issues that surround the confidentiality 
of medical records, particularly in relation to patients who are HIV positive. It records some 
historical background of the HIV epidemic, and considers the relative risks of transmission of 
HIV from individual to individual. It explains the law as it pertains to confidentiality, and reports 
the professional guidance in these matters. It then considers how these relate to HIV-positive 
individuals in particular.
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Introduction
In December 1981, an article appeared in the New England Journal of Medicine 
describing a curious cluster of just seven men who, for no apparent reason, had severe 
infections, previously associated only with profoundly immunologically compromised 
individuals.1 The mystery illness would soon enter common parlance as HIV and 
AIDS.
It is estimated that since the beginning of the epidemic, there have been 60 million 
people infected with HIV and 25 million HIV-related deaths.2
The introduction of highly active antiretroviral therapy (HAART) has led to a 
dramatic decline in morbidity and mortality among patients infected with HIV .3
The success of HAART has meant that in Britain and the North Western World, 
HIV/AIDS has been transformed from being a fatal disease to a chronic illness.4 Nev-
ertheless, HIV persists in infected individuals, who should be considered infectious for 
life.5 Ultimately, preventive vaccination will be the most efficient and cost-effective 
approach to stop the HIV epidemic.6 However, even optimistic estimates suggest a 
vaccine may not be available for a number of years,7 and even then may initially be 
only partially effective.8
In the United Kingdom, at the end of 2008, it was estimated that 83,000 people were 
living with HIV (1.3 people/1000 population). Over a quarter (27%) were unaware of 
their infection.9 In 2008, 7298 new HIV cases were diagnosed; almost a third (32%) 
was diagnosed late.9 Late diagnosis is associated with short-term mortality,10–12 impli-
cated in onward transmission of infection,13,14 and is associated with increased care and 
management costs.15,16 Reasons for late presentation with HIV infection are complex 
and poorly understood,17 but include concerns about confidentiality.18,19
The relatively specific sexual connotations associated with HIV infection, and 
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disease.21–23 AIDS-related stigma refers to the prejudice and 
discrimination directed at people living with AIDS, and can 
result in marginalization, discrimination, and even physical 
hurt.24 UN Secretary-General, Ban Ki-moon has been quoted 
as saying, ‘Stigma is a chief reason why the AIDS epidemic 
continues to devastate societies around the world’.24
More bluntly, Arthur Schaffer describes HIV/AIDS as 
‘God’s gift to bigots’.25 Inevitably then, individuals found 
to be HIV positive will have legitimate concerns about the 
confidentiality of their status.20
Public health, professional 
guidelines, and the law
Created in 2003, the remit of the Health Protection Agency 
(HPA)26 is the anticipation, identification, and rapid response 
to infectious disease, threats, and other health dangers. Effec-
tive health protection for the community depends on early 
detection, rapid and effective intervention and control, and 
ongoing surveillance of the situation. An essential element of 
this is the categorization of diseases as ‘notifiable’.26 A notifi-
able disease is one which a registered medical practitioner is 
legally bound to report to the relevant authorities, and failure 
to do so can result in summary conviction and fine. Notifiable 
diseases are defined in the Public Health (Control of Disease) 
Act 1984 for England and Wales27 and the Public Health 
(Infectious Diseases) Regulations 1988.28 The Secretary of 
State also has the powers to make such regulations as are 
required to respond to an immediate disease threat.29
HIV is not notifiable in the United Kingdom. Considering 
that infectious diseases such as hepatitis, mumps, and measles 
must be reported, the medical case for not making HIV noti-
fiable does not exist. However, given the social stigma that 
has surrounded the disease, the concern has always been that 
patients would perceive a forced breach of their confidential-
ity as a threat to their interests and would not return for care 
or refuse to come forward, leaving health authorities with no 
effective means by which they could monitor the disease.30
There is a tension then between HIV/AIDS as a personal 
issue and a matter for the individual, and as a social issue 
with public interest concerns.31
It seems likely that McNair’s man on the Clapham omni-
bus, the ordinary man32 would regard medical confidentiality 
as a straightforward matter, an expectation that details about 
a patient’s medical condition, and treatment remains a secret 
between the patient and those that treat him.33 Confidential-
ity is seen as ‘an essential requirement for the preservation 
of trust between patients and health professionals,’34 an 
unequivocal concept, deeply ingrained in oaths and strict 
guidelines.35–37 General Medical Council (GMC) guidance 
makes it clear that patients have a right to expect that informa-
tion about them will be held in confidence by their doctors.38 
This is easily applied to a historic model, with each patient 
cared for largely by a single physician keeping relatively 
few notes,39 but more difficult in current modern medical 
practice, with patients likely to be treated by a large number 
of health care professionals.39,40 Clinical records are quite 
widely circulated among professionals, some of whom may 
be less deeply indoctrinated than their medical colleagues 
in matters of confidentiality.20,41 The inevitable increase in 
computer technology makes protecting confidentiality more 
complex, and this has led some to shift the focus to the notion 
of data protection.40
It is argued that in reality, individuals have never been 
literally in control of their medical records, and what is lost 
is the ‘illusion’ that patients maintained control of their per-
sonal information disclosed as part of a patient–physician 
relationship.42
Moreover, it is not difficult to envisage a scenario where 
information given in confidence to a doctor should be 
revealed.43 Indeed, the Hippocratic Oath has doctors swear 
to keep secret and never reveal that ‘which ought not to be 
spread abroad,’ with the implication that circumstances might 
exist where this should happen.39
Revealing a patient’s confidential medical details might be 
said to be a breach of contract; this might be applied to private 
(non-National Health Service [NHS]) patients, but less eas-
ily applied to NHS patients where there is no contract with 
anyone caring for them.40 A breach of contract claim could 
also be raised if infringement of patient confidentiality was 
in effect a breach of the health care professional’s contract of 
employment.44 This remedy, however, would be open only to 
the employer, unless a patient could make a claim under the 
Contracts (Rights of Third Parties) Act 1999.40
If a medical professional either revealed or failed to 
take adequate steps to ensure that others did not discover a 
patient’s protected information, an action could be brought 
in tort for negligence.45 However, there may be only limited 
benefit for the claimant because tort damages are generally 
for financial or physical loss.40
The patient could rely on the equitable obligation to 
respect confidential information. Four criteria must be 
satisfied:
1.  The information must be personal, private, or intimate in 
nature.46,47
2.  The information must be given in circumstances that 
impose an obligation of confidence.Risk Management and Healthcare Policy 2011:4 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
17
Confidentiality of medical records in HIV
3.  It may be necessary to show that an individual must 
actually suffer from the release of the information. This 
might allow the release of anonymized information.48 
However, even if the revealed information does not harm 
a particular individual, it may be argued that a public harm 
arises (eg, distrust of doctors).49,50 Hence, it is accepted 
that even if a patient has died, details of his or her medical 
condition should not be made public.40
4.  A breach of confidence requires only that an unauthorized 
person sees the information. It does not have to be made 
public.51
A claim for breach of confidence could only be raised 
by the person to whom a duty of confidentiality is owed.52 
Clearly, the person who breaches the duty may be sued; 
however, an action could also be raised against someone who 
comes into possession of information, and despite knowing 
or suspecting that it is confidential publishes it.46
Although it could be argued that a patient owns the medi-
cal information that relates to him or her as an individual, 
and might therefore bring a property claim, it is generally 
accepted that it is the NHS Trust that owns the records made 
by its staff.48 In criminal law, information is not property 
capable of being stolen,53 although the paper on which it 
is written could be. Were someone to hand over a medical 
record to a third party, they could be guilty of theft, not of 
the information but of the record itself.40
The Computer Misuse Act 1990 does criminalize unau-
thorized access to databases of confidential information.54 This 
means a health care professional would be guilty of an offence 
under the act if they were to access records to gather informa-
tion about someone who was not in their professional care.
The European Convention on Human Rights article 8 
protects the right to respect for private and family life, and 
also protects confidential information. This was a prominent 
feature in Campbell v MGN,47 the leading case in breach of 
confidence. Article 8 should be considered as central to the 
protection of confidentiality.40 As the European Court of 
Human Rights (ECHR) explained in Z v Finland.55
The protection of personal data, not least medical data, is 
of fundamental importance to a person’s enjoyment of his or 
her right to respect for private and family life as guaranteed 
by article 8 of the convention. Without such protection those 
in need of medical assistance may be deterred from revealing 
such information of a personal and intimate nature as may 
be necessary in order to receive appropriate treatment, and 
even from seeking such assistance, thereby endangering their 
own health and, in the case of transmissible diseases, that of 
the community.
There have, however, been inconsistencies in the court’s 
judgment,56 and these fundamental rights are not absolute.57 In 
Z v Finland, the Finnish State was found to be in breach of Z’s 
privacy. The court stated that considerations of privacy were 
especially valid in the circumstances of Z’s seropositivity. 
However, seizing Z’s medical records and ordering her doc-
tors to give evidence did not violate article 8, because there 
were good reasons for requiring this information. Article 
8 (2) gives public authorities a broad margin for justify-
ing disclosure of medical information. Seizing Z’s medical 
records was not disproportionate; however, revealing her 
identity and allowing the information to become public was 
a disproportionate interference with her right to respect for 
her family and private life.39
I v Finland58 involved a district authority that failed to 
establish a register from which a HIV-positive employee’s 
confidential patient information could not be the subject 
of unauthorized disclosure. The court’s view was that it is 
insufficient to simply have remedies of compensation for the 
injured parties, and retrospective sanctions against those who 
have accessed the records unlawfully. The court required an 
assurance that domestic legislation contains sufficient safe-
guards to exclude the possibility of any such unauthorized 
access occurring.
It has been suggested that NHS databases in the United 
Kingdom may not be able to meet such a high threshold of 
protection, given that it would involve restricting access, and 
the maintenance of an audit trail of those who have accessed 
the clinical records.59
A number of statutes impose obligations in matters of 
confidential information. The Data Protection Act 1998 is the 
most significant, but the National Health Service (Venereal 
Diseases) Regulations 197460 and the Human Fertilisation 
and Embryology Act 199261 were introduced to give statu-
tory emphasis to the obligation of confidence in these areas 
of medical practice.
The National Health Service (Venereal Diseases) Regula-
tions 1974 impose a statutory duty on a health authority to 
enforce a duty of confidentiality, by virtue of the common 
law (or statute) between the patient and doctor or health 
authority.62 The obligation of confidence under the regula-
tions applies to sexually transmitted diseases. It has been 
suggested that patients, who are HIV positive following 
infection by some other means, may need to look to the 
common law for protection of their confidentiality.62 How-
ever, it can be argued that within the regulations, a sexually 
transmitted disease is a disease that is usually transmitted 
through sexual contact, but which may be transmitted by Risk Management and Healthcare Policy 2011:4 submit your manuscript | www.dovepress.com
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other means.62 On this   analysis, HIV remains within the 
regulations irrespective of the means of infection, and this 
is argued by Rose J in X v Y.44
The Data Protection Act covers the processing of all 
personal data stored in systems whether paper based or 
electronic. Health records are classified as sensitive personal 
data under the act and are subject to special protection.63 If 
a person suffers damage or loss as a result of violation of 
the act, he or she could receive compensation. Other stat-
utes create specific exceptions to the duty of confidentiality, 
requiring health professionals to disclose certain information, 
regardless of patient consent.64–70
In addition to the law, the various professional regula-
tory bodies issue guidelines on confidentiality. The GMC 
issued new guidelines on confidentiality in October 2009,71 
and the British Medical Association (BMA) has published 
extensive information and guidance on confidentiality and 
the disclosure of health information.34 A wide range of other 
policies and standards exist, providing guidance in matters 
of confidentiality, including the Caldicott Guardian Manual 
(2006), the Department of Health (DoH) Confidentiality: 
NHS code of practice (2003), the Scottish Government 
Health Directorate NHS Code of Practice on Protecting 
Patient Confidentiality (2003), and the Northern Ireland 
Code of Practice on Protecting Confidentiality of Service 
User Information.
The NHS Care Record Guarantee emphasizes the com-
mitment of the NHS to confidentiality and security of patient 
information.
Exceptions to the rules
The GMC guidelines remind doctors that though confi-
dentiality is an important duty, it is not absolute. Personal 
information can be disclosed if 1) it is required by the 
law, 2) the patient consents, and 3) it is justified in the public 
interest.71
A defense to alleged breach of confidentiality would be a 
threat of serious harm to others. Here, the public interest in 
protecting innocent people from harm outweighs the public 
interest in protecting confidentiality.40 This equitable notion, 
easily understood in principle, raises a number of questions. 
How serious must the harm be to others that would allow a 
breach of confidentiality; should an individual who poses a 
threat to others, perhaps through no fault of their own, be 
denied the protection of the law on confidence?
Another defense might be that the disclosure was justi-
fied in the public interest and to stimulate public debate.40 
The BMA and GMC guidance is clear: to justify disclosure 
there must be a real risk of serious harm. When considering 
disclosing information to protect the public interest, doctors 
must:
•  “Consider how the benefits of making the disclosure 
balance against the harms associated with breaching a 
patient’s confidentiality both to the individual clinical 
relationship and to maintaining public trust in a confi-
dential service.
•  Assess the urgency of the need for disclosure.
•  Persuade the patient to disclose voluntarily.
•  Inform the patient before making the disclosure and seek 
his or her consent, unless to do so would enhance the risk 
of harm or inhibit effective investigation.
•  Disclose the information promptly to the appropriate 
body.
•  Reveal only the minimum information necessary to 
achieve the objective.”34
•  Seek assurances that the information will be used only 
for the purpose for which it was disclosed and be able to 
justify the decision.34
Nonconsensual disclosure is generally only considered 
justifiable in cases where there is a threat to society or to an 
individual, of serious crime, or serious harm such as a serious 
communicable disease.71 Disclosure of personal information 
may be justified in the public interest, without the patient’s 
consent, and in exceptional circumstances where patients 
have withheld consent, if the benefits to an individual or 
to society of the disclosure outweigh both the public and 
patient’s interest in keeping the information confidential.71 
Doctors are advised to seek consent to disclosure where 
practicable, and to inform the patient about disclosure even 
if they have not sought consent, unless it was impracticable 
to do so.71
HIV/AIDS infection – the risks  
of transmission
The proportion of babies that acquire HIV infection 
from untreated HIV-seropositive mothers is 15%–25% in 
developed countries, and 25%–45% in developing coun-
tries.72 The frequency of HIV transmission attributable 
to breastfeeding is 16%.72 The risk of HIV transmission 
associated with orogenital sex exists, but is considered 
extremely low,72 although there are currently insufficient 
data to estimate the risk precisely.73 Studies of cumulative 
HIV incidence suggest that cofactors such as genital ulcer 
disease, HIV disease stage, and male circumcision influ-
ence HIV transmission.74 The heterosexual infectivity of 
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0.001 or 1 transmission/1000 contacts. However, this figure 
was estimated among stable couples with low prevalence 
of high-risk factors, and represents a lower bound.74 It has 
been suggested that estimates based on models assuming 
constant infectivity are likely to be misleading, underesti-
mating the risk after very few contacts, and overestimat-
ing the risk associated with a large number of contacts.75 
Unprotected anal intercourse in men who have sex with 
men is a high-risk practice for HIV transmission,76 but 
studies report a quite wide variation in seroconversion 
rates in different groups.77–79
People in the process of seroconverting may be much 
more infectious than asymptomatic infected people,80,81 and 
it is reported that primary- and late-stage HIV-1 infections 
are more infectious than previously thought.82 However, in 
a homogenous population, the asymptomatic stage of infec-
tion will typically contribute more to the net transmission of 
HIV-1 over the lifetime of an infected individual, because of its 
longer duration.82 Transmission from women to men appears 
less efficient than from men to women, as has been reported 
with other sexually transmitted diseases.83,84 Importantly, the 
consistent use of condoms has been shown to reduce HIV inci-
dence by 80%.85 However, it is recognized that HIV-positive 
individuals do not always inform their sexual partners of their 
serostatus,86,87 which may influence condom use.
It is important, when considering public health risk, to 
recognize that the virus does not pass from one person to 
another through ordinary day-to-day social contact.88,89
The HIV-positive patient
A doctor, on diagnosing a patient with HIV should explain 
to the patient:
•  How they can protect others from infection, including 
practical measures to avoid transmission of the virus.
•  The importance of informing sexual contacts about the 
risk of transmission.
•  That, unless they object, personal information about them 
will be shared within the health care team, including some 
nonclinical staff involved in their care.90
If the doctor is aware that a HIV-positive patient has not 
informed their sexual partner, it would be permissible for the 
doctor to alert that partner in order for them to take steps to 
avoid infection even if the patient refuses to consent to others 
being informed.39,40
  “… you may disclose information to a known sexual 
contact of a patient with a sexually transmitted, serious 
  communicable disease where you have reason to think 
that they are at risk of infection and that the patient has 
not informed them, and cannot be persuaded to do so. 
In such circumstances you should tell the patient before 
you make the disclosure, … you must be prepared to 
justify a decision to disclose personal information 
without consent.”90 ‘‘Information must not be disclosed 
to others eg, relatives who have not been and are not at 
risk of infection.”34
The advice leaves the responsibility for action entirely 
with the individual doctor,30 and is couched in terms of it 
being permissible to tell others, rather than there being a duty 
to tell others.40 Partner disclosure is a very complex issue, 
because of the diversity of types of relationships and varying 
levels of intimacy, power, and trust.91 A recent study reports 
that GPs were more likely, given hypothetical scenarios, 
to inform partners when protection was not used during 
intercourse and when heterosexual rather than homosexual 
relationships were involved. The risk to the partner only 
partially explained the relationship between patient use of 
protection and decision making. Physician background and 
characteristics, and HIV patient sexual practice and orienta-
tion are also involved.”92
In United Kingdom law, no duty to warn exists in 
the absence of a special relationship between the parties, 
although a number of cases in non-United Kingdom jurisdic-
tions suggest a common-law duty or statutory duty to inform 
those at risk.93–95 It is possible that in the United Kingdom, a 
doctor might be held to have a duty to warn a third party who 
was also his patient. Here, the relationship might be deemed 
sufficiently proximate to require positive action.30
The Human Rights Act places a duty on the state to pro-
tect the lives of citizens (Article 2) and protect them from 
inhuman or degrading treatment (Article 3), and also places 
a duty on the NHS to inform individuals at risk.40
In the United Kingdom, there has been no decision 
directly taken on this point. It is arguable that a patient 
would have a right of action against a doctor who informed 
a sexual partner of potential risk, as a prima facie breach 
of confidence. It seems likely that the court would balance 
the interests of those involved and hold the disclosure to be 
justified. The dilemma is that relaxation of the rule on confi-
dentiality might lead to failure to seek advice and treatment, 
and hence promote the spread of disease, whereas unyielding 
confidentiality denies to some the opportunity to avoid the 
risk of exposure or, in the event of exposure, to seek early 
treatment.30
It should be remembered that the Crown Prosecution 
Service (CPS) has successfully prosecuted a number of 
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HIV through unprotected, consensual intercourse to an 
unsuspecting partner, contrary to the recklessness provi-
sions of section 20 of the Offences Against the Person Act 
1861 (OAPA).96,97 Although the criminalization of HIV 
transmission has been criticized by some,98 it is clear that 
such prosecutions have been something of a priority for 
the CPS.99
In 2008, the CPS issued guidelines to clarify the law. As 
of 2008, a person can only be convicted of reckless sexual 
HIV transmission if there is, ‘… a sustained course of conduct 
during which the defendant ignores current scientific advice 
regarding the use of safeguards’. While recognizing concerns 
about discrimination, the guidelines go on to say.
“We will be mindful of any indications that there is a dis-
proportionate impact on any particular group of individuals 
that we may prosecute … however, where there is sufficient 
evidence and it is in the public interest to prosecute, the CPS 
has a duty to the complainant and to society at large to bring 
the defendant before the courts … .”100
Even supporters of the criminalization of HIV transmis-
sion agree that in the case of casual or commercial sex with 
strangers, the victim can be taken to have consented to the 
risks, and the victim’s consent prevents criminal liability.101
The 1861 act has never extended to Scotland. However, 
common law in Scotland has consistently recognized all 
intentionally inflicted physical injury to be criminal. The 
scope of intention clearly is an issue. However, the first 
successful prosecution for actual transmission of HIV was 
brought about in Scotland.102
In Scotland, the possibility exists of prosecution for the 
inchoate offence of reckless endangerment. This means that 
it could be possible in principle to convict an individual of 
reckless endangerment simply for having intercourse in the 
knowledge that he or she might be HIV positive even if it 
turns out that he or she is not.103
HIV-positive health care workers
‘Any departure from the strictest anonymity in respect of HIV-
related information must be subject to intense scrutiny’.30 
HIV-positive health care workers (HCW) have come under 
particular scrutiny. The low risk of transmission from HCW 
to patient is estimated variously as ranging from 1 in 42,000 
to 1 in 1,000,000,104 or unlikely to occur more frequently than 
once/1000 person-hours of surgical exposure.105 Scully and 
Porter in a review of the CDC studies106 concluded that HIV 
transmission from HCW to patient is exceedingly improbable 
and almost impossible where recommended infection-control 
procedures are implemented.
There has been no known case in the United Kingdom 
of HIV infection being transmitted from a HCW to a 
patient.107 Nevertheless, worldwide there have been three 
reports of transmission of HIV to patients from HCWs 
performing exposure-prone procedures (EPPs): a Florida 
dentist,108 a French orthopedic surgeon,109 and a   Spanish 
obstetrician.110 The exact route of transmission in these cases 
has not been determined.107 There is also an unusual case that 
occurred in France, where a HIV-infected nurse transmitted 
the virus to a patient, where again no defined route of trans-
mission has been determined.111 In addition, there has been 
one case of patient-to-patient transmission of HIV , where 
a Sydney surgeon, whose breaches of proper procedures 
led to the transmission of HIV from a HIV-positive male to 
four women who had visited the surgeon’s rooms for minor 
surgery.112 The surgeon himself was not HIV positive.
The UK policy and guidance relating to HIV-infected 
HCWs is set out in a Department of Health (DoH) 
report.113
•  Healthcare workers have legal and ethical duties to protect 
the health and safety of their patients. They also have a 
right to respect and protection of their confidentiality.
•  In the majority of cases, HIV infected healthcare workers 
do not present a risk of transmission to patients in the 
healthcare setting; providing appropriate infection control 
measures are maintained.
•  Circumstances in which HIV could be transmitted from 
a healthcare worker to a patient are limited to exposure 
prone procedures, which it goes on to define. Essentially, 
these arise where injury to the healthcare worker could 
result in the worker’s blood contaminating the patient’s 
open tissues (bleed-back). HIV infected healthcare worker 
must not perform any exposure prone procedures, which 
are defined in the report.
•  HIV infected healthcare workers must seek advice and not 
rely on their own assessment of their risk to patients.113
The DoH guidance goes on to place a burden on profes-
sional colleagues, knowing of a HIV-infected individual 
practicing in a way which places patients at risk, to inform an 
appropriate person in the HCW’s employing authority, or the 
relevant regulatory body, and this is reinforced in the GMC 
guidance.90 A doctor then, while having a duty of confiden-
tiality to the infected HCW, would be required to disclose 
information in the public interest to protect others.114
For many HCWs, HIV seropositivity is not a barrier to 
normal working practice.113 For others, changes in working 
routine have been a prerequisite of being allowed to continue 
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health checks, a requirement for patients to sign a consent 
form stating that they knew that the HCW (a surgeon) was 
HIV positive, and the opportunity for patients to ask to be 
treated by another surgeon if they so wished.115 Some (eg, 
dentists) despite challenges to the scientific basis for the 
decision,116–118 are obliged to cease contemporary clinical 
practice.119
The identification of HCWs with a positive-HIV diagno-
sis has led to multiple patient notification exercises (look-
back procedures).113,120–122
With the exception of a French orthopedic surgeon, look-
back procedures have conspicuously failed to identify any 
transmission of HIV from an infected HCW to a patient,123–125 
but inevitably led to the identification of the HCW’s HIV 
status to all patient contacts.
The low risk of transmission has called into question 
the value of look-back procedures, which are considered 
disruptive and expensive, and it is claimed that they should 
no longer be routinely recommended.121,126,127 Since 2003, 
DoH guidance has advised that look-back procedures take 
place in rare circumstances only.128 Nevertheless, others argue 
forcefully that look-back procedures are important,129 and 
they continue to be set in motion.130,131
The 2003, DoH guidance followed the case of H (a HCW) 
v Associated Newspapers Ltd.132 H’s respect for private life133 
was set against the right to freedom of expression of the 
press.134 H also challenged the right of the health authority 
to undertake a look-back procedure.
In balancing the tension between articles 8 and 10 of the 
Human Rights Act, the appeal court held that there was a 
public interest in maintaining H’s confidentiality, and upheld 
the injunction against naming H or N (the health authority). 
However, the risk of discovery of H’s identity was insuf-
ficient to continue restriction on disclosure of his specialty 
(as a dentist), as this was deemed a matter of public interest 
worthy of debate.
Similarly, although the court was clear about the public 
interest in preserving the confidentiality of HIV-positive 
HCWs if they are not to be discouraged from coming for-
ward, and that all possible steps should be taken to preserve 
their anonymity, it recognized that it may prove impossible 
to prevent identification of the worker. The court took the 
view that look-back procedures were a matter of patient 
safety and that the anonymity of the HCW may have to be 
sacrificed in the interest of patients.
The rationality of public and media response to the 
knowledge of HCWs diagnosed as HIV positive has   varied.135 
However, surveys have shown that patients do want to 
know if their doctor or dentist is infected with HIV ,136,137 
and this may be a factor in determining valid consent for 
treatment.138,139
The issues surrounding HIV-infected HCWs require 
actions based on “a realistic and scientifically accurate deter-
mination of the risk of infection, which do not needlessly 
violate the core political values that underwrite a free and 
democratic society.”140 The burden of proof should lie on 
those who seek to limit the rights of people with HIV . This 
is important if the rights of the HIV-positive minority in the 
community are not to be overturned because of the demands 
of an apprehensive majority. Currently, it would seem that 
the merest possibility of a risk is sufficient to justify what 
may otherwise be regarded as unequal and right-infringing 
treatment.140
In 1986, the Centers for Disease Control and Prevention 
stated that mandatory HIV screening of HCWs who per-
formed invasive procedures was not necessary because 
testing would not further reduce the ‘negligible risks of 
transmission’.141 The 2007 DoH guidance142 requires HCWs 
who are new to the NHS and carry out EPPs to have additional 
health clearance checks to demonstrate they are free from 
infection with hepatitis BV , hepatitis C, HIV , and Tuberculo-
sis. Medical and dental students are also required to undergo 
additional health clearance before being accepted onto their 
course. The new guidelines have been criticized,143 and it has 
been argued that in effect mandatory HIV testing has now 
been introduced for a large number of HCWs.144
Appropriate information sharing is essential to the effi-
cient provision of safe, effective care for individual and the 
wider community of patients.71
If a patient refuses to allow information to be passed 
to someone outside the health care team of their infection 
status, their wishes must be respected, unless it is felt that 
failure to disclose the information will put other HCWs or 
other patients at risk.
The risk of transmission from patient to HCW is low, with 
a seroconversion rate of 0.1% after percutaneous exposure, 
and 0.63% after mucous membrane contamination, and the 
use of universal procedures should be enough to protect 
HCWs from infection, thereby making disclosure unnecessary 
to prevent serious harm.145 Notwithstanding this, there have 
been a number of recorded occupational infections.146 The 
combined risk of contracting HIV infection from the source 
patient and then transmitting it to another during an EPP is 
so low as to be considered negligible, and HCWs are not 
required to refrain from performing EPPs pending follow-up 
of occupational exposure to a HIV-infected source.113Risk Management and Healthcare Policy 2011:4 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
22
Williams
Prisons represent a high-risk environment for HIV 
transmission,147 as those engaging in high-risk behavior are 
disproportionately represented in the prison system.148 The 
prison service does have confidentiality policies that are 
largely convention-compliant; however, local application 
of these policies can be inconsistent and there are common 
breaches of confidentiality.
The Health and Social Care Act 2001 allows the disclo-
sure of medical information for research purposes without a 
patient’s consent, if it is necessary or expedient in the interests 
of improving patient care, or in the public interest.
The GMC guidance acknowledges that in most cases 
it will be possible to engage patient consent or to use ano-
nymized or coded data, but goes on to provide guidance 
should this not be possible.71 The BMA advises a cautious 
approach, unless the health professional is confident that 
they can make a reasonable assessment as to whether or 
not the research is in the public interest.34 The training of 
medical staff, clinical research, and medical audit require 
access to patient information. It has been suggested that 
the emphasis on confidentiality is an interference with 
research.149
It can be argued that the use of medical records in an 
epidemiological study, with no intention to disclose patient 
identity, reduces the public interest in maintaining secrecy 
in favor of the public interest in health care provision.39 
In R v Department of Health ex parte Source Informatics 
Ltd,150 the Court of Appeal’s view was that the general 
public would not object to their medical information being 
used if it was anonymized. The decision takes no account 
of the fact that a patient’s information might be used in 
a way that indirectly harms them, particularly so in an 
already vulnerable group. The decision has been criticized 
as virtually abolishing the duty of confidence in the face of 
competing commercial and research interests.151 In fact, it 
has been shown that public acceptability regarding the use 
of medical records cannot be assumed.152 It has been argued 
that a more important aspect of the decision in Source 
Informatics is to move the focus away from the protection 
of confidential information to fairness of use, a shift away 
from protection of patients’ privacy to an attention on the 
conscience of the user.40
GMC guidelines are clear that the duty of confidential-
ity continues after a patient has died.71 This is an ethical 
and moral duty; it is thought that legal duty of confiden-
tiality expires with the patient.39 The cause of death, as 
written on a death certificate, in effect, becomes public   
knowledge.
Discussion
Patients value their right to confidentiality,153 and are reported 
to have high levels of confidence in the way the NHS pro-
tects their confidentiality.154 However, they may have limited 
knowledge of the type of information held in their records,155 
and are not always well informed about how the information 
is used.154 Patients have clear opinions about who should have 
access to their records, with a substantial minority wishing 
to restrict it,156 having particular unease about information 
being passed to people outside the NHS.154
The introduction of a national electronic health record 
system has raised issues about security and confidential-
ity. Unsurprisingly, patients are keen to censor information 
that relates to sensitive or embarrassing issues, which may 
affect the way a patient may be treated by other individuals 
or institutions, being shared on the national electronic data-
base.157 English Law does not recognize a general right of 
privacy.158 Courts have been willing to protect the identity 
of HIV-positive individuals,159 but sometimes confine their 
decision to very narrow grounds.160
“HIV infection is a very personal issue and a matter 
for the individual, but it is also a public and social issue.”31 
The effectiveness of public health measures in checking 
the epidemic must be weighed against the sacrifices those 
measures demand of individual citizens.140 It has been 
stated that the law is at best limited in its ability to tackle 
the AIDS threat.31 Medically and legally, HIV/AIDS appears 
to be less of a widespread problem in the United Kingdom 
than in much of the world,161 and it seems that for a variety 
of reasons, people living in Britain with HIV/AIDS do not 
litigate. Consequently, legislation that may assist them 
remains underused.162
Reasons why people do not litigate are complex, but 
appear to be related to publicity generated by litigation, and 
the low levels of compensation for unlawful treatment.161 
It has also been reported that people with HIV/AIDS are 
reluctant to take legal advice even when they feel they have 
suffered discrimination.163
It is argued that the central weakness of HIV/AIDS law 
in the United Kingdom stems from the fact that litigants and 
their advisers readily settle out of court, and thus the law 
remains underdeveloped.161
Even among the general population, few cases are brought 
in matters of confidentiality. Two remedies would be available 
to a claimant: an injunction to prevent publication, and the 
award of damages. An injunction would of necessity require 
advance notice of disclosure of the information. More usually, 
the patient would only become aware of the disclosure after Risk Management and Healthcare Policy 2011:4 submit your manuscript | www.dovepress.com
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the event, and the court would still need to be convinced that 
there was no public interest element.
Since the Human Rights Act, courts have robustly pro-
tected the individual’s rights to confidentiality of health 
data.165,166 Confidentiality of health data is seen as a vital 
principle in the legal system, crucial not only to respect the 
sense of privacy of a patient, but to preserve confidence in the 
medical profession and in health services in general.58
Campbell v MGN establishes the right to protection of 
private information in English Common Law, and identifies 
three tests:
1.  ‘… reasonable expectation test’
2.  ‘… highly offensive to a reasonable person of ordinary 
sensibilities test’
3.  ‘… obviously private’59
HIV-positive patients might justifiably have a reasonable 
expectation that their medical records remain confidential.
Finally, no discussion of HIV/AIDS can fail to recognize 
that in general, HIV is increasingly a disease of poverty,166 with 
a disproportionate impact on racial and ethnic minorities.167 
Many in this already disadvantaged and stigmatized group 
will be least able to protect their rights of confidentiality.
Conclusion
Confidentiality is a fundamental principle, grounded in 
the patient’s right to autonomy, and enabling the patient to 
have an open and honest dialogue with his or her medical 
professional, with benefits to the individual and the general 
public health.
For most individuals, the main cause for concern is 
likely to be the casual social disclosure of their HIV status. 
Although there may be a whole raft of legislation, ultimately, 
there will still be a heavy reliance on the moral and ethical 
standards of the medical profession.
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